News
Texas governor Greg Abbott announced that NtxBio, a Rio Rancho, New Mexico healthcare biomanufacturing company, is building a ...
Female entrepreneurs in the field of biotech, fashion, and beauty technology led workshops to give girls creativity, confidence, and ...
Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.
Biohaven is giving investors whiplash. Forty-eight hours after saying its filing was on track, the biopharma revealed the FDA ...
By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...
Some of it is in the new Boston home of Eli Lilly & Co ., a $700 million research and development facility along Fort Point ...
The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...
Amidst policy shifts and layoffs at the FDA, some biotechs are considering moving early clinical trials to Europe or ...
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...
A very different kind of “hog farm” being built by United Therapeutics Corp. on the edge of Stewartville to raise gene-edited ...
The latest health news highlights Sanofi's $20 billion U.S. investment through 2030, Merck's cancer drug expansion and the ...
St. Renatus LLC, a Fort Collins-based biopharmaceutical company that won Food and Drug Administration approval nine years ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results